It is also decisive for the promotion of either CD4+ T regulatory cells or CD8+ cytotoxic T cells, which is important because CD4+ cells were found to limit the anti-tumor effects of IL-2, while CD8+ cells promote these outcomes [9,10]. The gene discussed is CD8A; the disease is neoplasm.